Skip to menu Skip to content Skip to footer

2007

Journal Article

Resistant hypertension

Johnson D.W. (2007). Resistant hypertension. Australian Doctor (20/APR)

Resistant hypertension

2007

Journal Article

Isolation, propagation and characterization of primary tubule cell culture from human kidney (Methods in Renal Research)

Qi, Weier, Johnson, David W., Vesey, David A., Pollock, Carol A. and Chen, Xinming (2007). Isolation, propagation and characterization of primary tubule cell culture from human kidney (Methods in Renal Research). Nephrology, 12 (2), 155-159. doi: 10.1111/j.1440-1797.2007.00779.x

Isolation, propagation and characterization of primary tubule cell culture from human kidney (Methods in Renal Research)

2007

Journal Article

Drug dosing adjustment in people with reduced GFR

Mathew, Timothy, Jones, Graham and Johnson, David (2007). Drug dosing adjustment in people with reduced GFR. Australian Prescriber, 30 (2), 34-34.

Drug dosing adjustment in people with reduced GFR

2007

Journal Article

Silibinin inhibits renal cell carcinoma via mechanisms that are independent if insulin-like growth factor-binding protein 3

Cheung, Catherine W., Vesey, David A., Nicol, David L. and Johnson, David W. (2007). Silibinin inhibits renal cell carcinoma via mechanisms that are independent if insulin-like growth factor-binding protein 3. BJU International, 99 (2), 454-460. doi: 10.1111/j.1464-410X.2007.06571.x

Silibinin inhibits renal cell carcinoma via mechanisms that are independent if insulin-like growth factor-binding protein 3

2007

Journal Article

Potential physiological and pathophysiological roles for protease-activated receptor-2 in the kidney

Vesey, David A., Hooper, John D., Gobe, Glenda C. and Johnson, David W. (2007). Potential physiological and pathophysiological roles for protease-activated receptor-2 in the kidney. Nephrology, 12 (1), 36-43. doi: 10.1111/j.1440-1797.2006.00746.x

Potential physiological and pathophysiological roles for protease-activated receptor-2 in the kidney

2007

Journal Article

Predictors of renal recovery in Australian and New Zealand end-stage renal failure patients treated with periotoneal dialysis

Craven, Ann-Maree S., Hawley, Carmel M., McDonald, Stephen P., Rosman, Johan B., Brown, Fiona G. and Johnson, David W. (2007). Predictors of renal recovery in Australian and New Zealand end-stage renal failure patients treated with periotoneal dialysis. Peritoneal Dialysis International, 27 (2), 184-191. doi: 10.1177/089686080702700216

Predictors of renal recovery in Australian and New Zealand end-stage renal failure patients treated with periotoneal dialysis

2007

Journal Article

Erythropoietin administration protects against functional impairment and cell death after ischaemic renal injury in pigs

Forman, Colin J., Johnson, David W. and Nicol, David L. (2007). Erythropoietin administration protects against functional impairment and cell death after ischaemic renal injury in pigs. BJU International, 99 (1), 162-165. doi: 10.1111/j.1464-410X.2006.06505.x

Erythropoietin administration protects against functional impairment and cell death after ischaemic renal injury in pigs

2007

Journal Article

Mineral metabolism, bone histomorphometry and vascular calcification in alternate night nocturnal haemodialysis

Van Eps, Carolyn, Jeffries, Janine K., Anderson, John A., Bergin, Patrick T., Johnson, David W., Campbell, Scott B., Carpenter, Sally M., Isbel, Nicole M., Mudge, David W. and Hawley, Carmel M. (2007). Mineral metabolism, bone histomorphometry and vascular calcification in alternate night nocturnal haemodialysis. Nephrology, 12 (3), 224-233. doi: 10.1111/j.1440-1797.2006.00712.x

Mineral metabolism, bone histomorphometry and vascular calcification in alternate night nocturnal haemodialysis

2007

Journal Article

Evaluation of renal function: CARI guidelines

Johnson, David W. (2007). Evaluation of renal function: CARI guidelines. Australian Family Physician, 36 (1-2), 46-46.

Evaluation of renal function: CARI guidelines

2007

Journal Article

Administration of erythropoietin and its derivatives in renal disease: advantages, mechanisms and concerns

Gobe, Glenda C., Endre, Zoltan H. and Johnson, David W. (2007). Administration of erythropoietin and its derivatives in renal disease: advantages, mechanisms and concerns. Drug Discovery Today: Therapeutic Strategies, 4 (1), 79-84. doi: 10.1016/j.ddstr.2007.07.001

Administration of erythropoietin and its derivatives in renal disease: advantages, mechanisms and concerns

2007

Journal Article

Central obesity is common in renal transplant recipients and is associated with increased prevalence of cardiovascular risk factors

Orazio, Linda, Armstrong, Kirsty, Banks, Merrilyn, Johnson, David, Isbel, Nikky and Hickman, Ingrid (2007). Central obesity is common in renal transplant recipients and is associated with increased prevalence of cardiovascular risk factors. Nutrition & Dietetics, 64 (3), 200-206. doi: 10.1111/j.1747-0080.2007.00151.x

Central obesity is common in renal transplant recipients and is associated with increased prevalence of cardiovascular risk factors

2007

Journal Article

The International Prognostic Index: the “gold-standard” in post-transplant lymphoproliferative disorders after renal transplantation

Hourigan, M. J., Mollee, P. N., Gill, D. S., Doecke, J., Norris, D., Johnson, D. W. and Gandhi, M. K.. (2007). The International Prognostic Index: the “gold-standard” in post-transplant lymphoproliferative disorders after renal transplantation. American Journal of Transplantation, 7, 399-399.

The International Prognostic Index: the “gold-standard” in post-transplant lymphoproliferative disorders after renal transplantation

2007

Journal Article

Modification of cardiovascular risk in hemodialysis patients: an evidence-based review

Johnson, David W., Craven, Ann-Maree and Isbel, Nicole Maree (2007). Modification of cardiovascular risk in hemodialysis patients: an evidence-based review. Hemodialysis International, 11 (1), 1-14. doi: 10.1111/j.1542-4758.2007.00146.x

Modification of cardiovascular risk in hemodialysis patients: an evidence-based review

2007

Journal Article

Update for GPs on the management of mild to moderate renal impairment.

Mathew, T. and Johnson, D. (2007). Update for GPs on the management of mild to moderate renal impairment.. Medical Observer, 31-34.

Update for GPs on the management of mild to moderate renal impairment.

2006

Journal Article

Pyrrolidine dithiocarbamate exerts anti-proliferative and pro-apoptotic effects in renal cell carcinoma cell lines

Morais, Christudas, Pat, Betty, Gobe, Glenda, Johnson, David W. and Healy, Helen (2006). Pyrrolidine dithiocarbamate exerts anti-proliferative and pro-apoptotic effects in renal cell carcinoma cell lines. Nephrology Dialysis Transplantation, 21 (12), 3377-3388. doi: 10.1093/ndt/gfl543

Pyrrolidine dithiocarbamate exerts anti-proliferative and pro-apoptotic effects in renal cell carcinoma cell lines

2006

Journal Article

A randomized controlled trial of coiled versus straight swan-neck tenckhoff catheters in peritoneal dialysis patients

Johnson, David W., Wong, Jennifer, Wiggins, Kathryn J., Kirwan, Robyn, Griffin, Anthony, Preston, John, Wall, Daryl, Campbell, Scott B., Isbel, Nicole M., Mudge, David W., Hawley, Carmel M. and Nicol, David L. (2006). A randomized controlled trial of coiled versus straight swan-neck tenckhoff catheters in peritoneal dialysis patients. American Journal of Kidney Diseases, 48 (5), 812-821. doi: 10.1053/j.ajkd.2006.08.010

A randomized controlled trial of coiled versus straight swan-neck tenckhoff catheters in peritoneal dialysis patients

2006

Journal Article

Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis

Teigen, Mette Maja B., Duffull, Stephen, Dang, Lily and Johnson, David W. (2006). Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis. Journal of Clinical Pharmacology, 46 (11), 1259-1267. doi: 10.1177/0091270006292987

Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis

2006

Journal Article

Cardiorespiratory fitness is related to physical inactivity, metabolic risk factors, and atherosclerotic burden in glucose-intolerant renal transplant recipients

Armstrong, Kirsten, Rakhit, Dhrubo, Jeffriess, Leanne, Johnson, David, Leano, Rodel, Prins, John, Garske, Luke, Marwick, Thomas and Isbel, Nicole (2006). Cardiorespiratory fitness is related to physical inactivity, metabolic risk factors, and atherosclerotic burden in glucose-intolerant renal transplant recipients. Clinical Journal of The American Society of Nephrology, 1 (6), 1275-1283. doi: 10.2215/CJN.00210106

Cardiorespiratory fitness is related to physical inactivity, metabolic risk factors, and atherosclerotic burden in glucose-intolerant renal transplant recipients

2006

Journal Article

Effect of aggressive risk factor modification on cardiac events and myocardial ischaemia in patients with chronic kidney disease

Rakhit, D. J., Marwick, T. H., Armstrong, K. A., Johnson, D. W., Leano, R. and Isbel, N. M. (2006). Effect of aggressive risk factor modification on cardiac events and myocardial ischaemia in patients with chronic kidney disease. Heart, 92 (10), 1402-1408. doi: 10.1136/hrt.2005.074393

Effect of aggressive risk factor modification on cardiac events and myocardial ischaemia in patients with chronic kidney disease

2006

Journal Article

Novel renoprotective actions of erythropoietin: New uses for an old hormone

Johnson, David W., Forman, Colin and Vesey, David A. (2006). Novel renoprotective actions of erythropoietin: New uses for an old hormone. Nephrology, 11 (4), 306-312. doi: 10.1111/j.1440-1797.2006.00585.x

Novel renoprotective actions of erythropoietin: New uses for an old hormone